A new cancer treatment implant that slowly releases drugs directly into cancerous tumours has had its first clinical trial in New Zealand and is touted as a major advance in the treatment of prostate cancer.

Initially developed to treat breast cancer, the “Biolen” device has been adapted to treat prostate cancer by delivering slow-release drugs directly into affected prostates which should reduce side effects.

If successful, the device could avoid surgery for some sufferers of prostate cancer. Read More